While well-known driver mutations such as JAK2, CALR, and MPL play a central role in MPN development, emerging research indicates the significance of passenger mutations or co-mutations in shaping the evolution of MPN clones. The gene discussed is JAK2; the disease is myeloproliferative neoplasm.